Evidence map›Paper›PMID 37150844›Full record

ArticleAnnals of clinical and translational neurology2023

Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt/β-catenin signaling pathway.

Yuhui Li, Xuan Zheng, Jiangong Wang, Mingyang Sun, Dan Li, Zhuo Wang, Jingwu Li, Yufeng Li, Yongliang Liu

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Biomolecules · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. The Glioblastoma CircularRNAome.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Yuhui LiDepartment of Neurosurgery, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Xuan ZhengThe Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Jiangong WangDepartment of Chemoradiotherapy, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Mingyang SunDepartment of Neurosurgery, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Dan LiThe Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Zhuo WangThe Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Jingwu LiThe Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Yufeng LiThe Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.
Yongliang LiuDepartment of Neurosurgery, Tangshan People's Hospital, Tangshan, Hebei, 063001, China.ORCID 0000-0002-4882-9008
Tangshan People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlioblastoma (GBM) is the most aggressive brain tumor. Reportedly, circular RNAs (circRNAs) participate in regulation of the development and progression of diverse cancers, including GBM.

methodsDysregulated circRNAs in GBM tissues were screened out from GEO database. The expression of candidate circRNAs in GBM cells was measured by qRT-PCR. Loss-of function assays, including colony formation assay, EdU assay, TUNEL assay, and flow cytometry analysis were conducted to determine the effects of circ-AHCY knockdown on GBM cell proliferation and apoptosis. Animal study was further used to prove the inhibitory effect of circ-AHCY silencing on GMB cell growth. Mechanistic experiments like luciferase reporter, RNA pull-down and RNA-binding protein immunoprecipitation (RIP) assays were performed to unveil the downstream molecular mechanism of circ-AHCY. Nanosight Nanoparticle Tracking Analysis (NTA) and PKH67 staining were applied to identify the existence of exosomes.

resultsCirc-AHCY was confirmed to be highly expressed in GBM cells. Circ-AHCY silencing suppressed GBM cell proliferation both in vitro and in vivo. Mechanistically, circ-AHCY activates Wnt/β-catenin signaling pathway by sequestering miR-1294 to up-regulate MYC which activated CTNNB1 transcription. It was also found that circ-AHCY recruited EIF4A3 to stabilize TCF4 mRNA. Enhanced levels of TCF4 and β-catenin contributed to the stability of TCF4/β-catenin complex. In turn, TCF4/β-catenin complex strengthened the transcriptional activity of circ-AHCY. Exosomal circ-AHCY derived from GBM cells induced abnormal proliferation of normal human astrocytes (NHAs).

conclusionExosomal circ-AHCY forms a positive feedback loop with Wnt/β-catenin signaling pathway to promote GBM cell growth.

Indexed as

GlioblastomaMicroRNAsAnimalsbeta CateninCell ProliferationDEAD-box RNA HelicasesEukaryotic Initiation Factor-4AHumansRNA, CircularWnt Signaling Pathwaybeta CateninDEAD-box RNA HelicasesEIF4A3 protein, humanEukaryotic Initiation Factor-4AMicroRNAsMIRN1294 microRNA, humanRNA, Circular

Identifiers

PMID37150844
PMCPMC10270256
OpenAlexW4375856187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.